Medical Director, Providence Cancer Institute
Oncology
Dr. Michael J. Kraut, MD
|
|
Give Review
Michael Kraut practices Oncology. He went to Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63 in research and 85 in primary care medicine Michael J. Kraut is a published MD. He has 53 papers published. The most current publication "Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer."
Publications
- The Effects of Amnestic Mild Cognitive Impairment on Go/NoGo Semantic Categorization Task Performance and Event-Related Potentials.
- Reproducibility of detecting silent cerebral infarcts in pediatric sickle cell Anemia.
- Electrophysiological spatiotemporal dynamics during implicit visual threat processing.
- Controlled trial of transfusions for silent cerebral infarcts in sickle cell Anemia.
- Age-related changes in feature-based object memory retrieval as measured by event-related potentials.
- Trimodality Therapy for Superior Sulcus Non-Small Cell Lung Cancer: Southwest Oncology Group-Intergroup Trial S0220.
- Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung Cancer.
- Depressive symptoms and Brain volumes in older adults: a longitudinal magnetic resonance imaging study.
- Phase II study of celecoxib and docetaxel in non-small cell lung Cancer (NSCLC) patients with progression after platinum-based therapy.
- Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung Cancer.
- The role of postoperative irradiation in the treatment of locally recurrent incompletely resected extra-abdominal desmoid tumors.
- The role of irradiation in the management of locally recurrent non-metastatic soft tissue sarcoma of extremity/trunkal locations.
- Gemcitabine and cisplatin in unresectable Malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
- Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung Cancer.
- Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the Lungs.
- InDuction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergrou...
- Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemi...
- Advanced bronchioloalveolar Carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.
- Evaluation of epothilone B Analog in advanced soft tissue sarcoma: a phase II study of the phase II consortium.
- Spectra of antinuclear antibodies in patients with squamous cell Carcinoma of the lung and of the head and neck.
- Longitudinal magnetic resonance imaging studies of older adults: a shrinking Brain.
- Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: Analysis of prognostic factors.
- Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast Cancer.
- InDuction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Inte...
- A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung Cancer.
- Phase II trial of gemcitabine in patients with previously untreated metastatic Cancer of the esophagus or gastroesophageal junction.
- One-year age changes in MRI Brain volumes in older adults.
- Phase II study of dolastatin-10 in patients with advanced non-small-cell lung Cancer.
- A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung Cancer.
- 'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast Cancer: a Southwest Oncology Group Phase II Study.
- Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung Cancer.
- Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung Cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical ...
- Antinuclear antibodies as potential markers of lung Cancer.
- Lung Cancer in patients < 50 years of age: the experience of an academic multidisciplinary program.
- Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung Cancer.
- Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung Cancer.
- Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung Cancer cell line.
- Evaluation of pyrazoloacridine in patients with advanced pancreatic Carcinoma.
- Autoimmunity to collagen in human lung Cancer.
- Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934).
- Effects of rhG-CSF, 5-fluorouracil and extramedullary irradiation on murine megakaryocytopoiesis in vivo.
- Chemoradiotherapy of esophageal Carcinoma.
- A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic Malignant melanoma.
- Effect of calcium replacement on the hemodynamic changes associated with high dose interleukin-2 therapy.
- Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with Cancer.
- Initial experience with a practical hyperfractionated accelerated radiotherapy regimen.
- 5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung Cancer.
- A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic coloRectal carcinoma.
- Phase II study of deoxydoxorubicin in previously untreated metastatic breast Cancer.
- A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with Cancer.
- Preoperative combination chemotherapy for advanced stage head and neck Cancer. Promising early results.
- West Nile virus neuroinvasive Disease: neurological manifestations and prospective longitudinal outcomes.
Schools
Wayne State University
Wayne State University Affil Hospital
Northwestern University
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
McGaw Medical Center of Northwestern University -
Wayne State University School of Medicine
Hospital
-
St. John Hospital and Medical Center -
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1114926805 | |
| NPPES Provider LastName | KRAUT | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 480753707 | |
| NPPES Provider State | MI | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 439.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 53.0 | |
| Percent Opioid Claims | 12.07 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114926805 |
| Last Name Of The Provider | KRAUT |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Andrew A. Muskovitz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick W. McLaughlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajendra K. Manam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anibal Drelichman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clarence B. Vaughn, MD
This Doctor is OpenDoctor Recommended.
|